{
  "headline": "Health Care; Shkreli Faces New Suit Over High-Priced Drug",
  "abstract": "A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.",
  "lead_paragraph": "WASHINGTON — Martin Shkreli, a former pharmaceutical executive serving a seven-year prison sentence for defrauding investors, was accused on Monday of trying to maintain a monopoly over the lifesaving drug Daraprim through anticompetitive tactics.",
  "keywords": [
    "Shkreli, Martin (1983- )",
    "James, Letitia",
    "Federal Trade Commission",
    "Antitrust Laws and Competition Issues",
    "Drugs (Pharmaceuticals)",
    "Toxoplasmosis",
    "Vyera Pharmaceuticals LLC"
  ],
  "print_page": "2"
}